CRISPR-Cas guide RNA indel analysis using CRISPResso2 with Nanopore sequencing data.
- Publisher:
- SPRINGERNATURE
- Publication Type:
- Journal Article
- Citation:
- BMC Res Notes, 2024, 17, (1), pp. 205
- Issue Date:
- 2024-07-26
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
| Field | Value | Language |
|---|---|---|
| dc.contributor.author | McFarlane, GR | |
| dc.contributor.author | Polanco, JVC | |
| dc.contributor.author |
Bogema, D |
|
| dc.date.accessioned | 2024-08-21T03:49:01Z | |
| dc.date.available | 2024-07-10 | |
| dc.date.available | 2024-08-21T03:49:01Z | |
| dc.date.issued | 2024-07-26 | |
| dc.identifier.citation | BMC Res Notes, 2024, 17, (1), pp. 205 | |
| dc.identifier.issn | 1756-0500 | |
| dc.identifier.issn | 1756-0500 | |
| dc.identifier.uri | http://hdl.handle.net/10453/180449 | |
| dc.description.abstract | OBJECTIVE: Insertion and deletion (indel) analysis of CRISPR-Cas guide RNAs (gRNAs) is crucial in gene editing to assess gRNA efficiency and indel frequency. This study evaluates the utility of CRISPResso2 with Oxford Nanopore sequencing data (nCRISPResso2) for gRNA indel screening, compared to two common Sanger sequencing-based methods, TIDE and ICE. To achieve this, sheep and horse fibroblasts were transfected with Cas9 and a gRNA targeting the myostatin (MSTN) gene. DNA was subsequently extracted, and PCR products exceeding 600 bp were sequenced using both Sanger and Nanopore sequencing. Indel profiling was then conducted using TIDE, ICE, and nCRISPResso2. RESULTS: Comparison revealed close correspondence in indel formation among methods. For the sheep MSTN gRNA, indel percentages were 52%, 58%, and 64% for TIDE, ICE, and nCRISPResso2, respectively. Horse MSTN gRNA showed 81%, 87%, and 86% edited amplicons for TIDE, ICE, and nCRISPResso2. The frequency of each type of indel was also comparable among the three methods, with nCRISPResso2 and ICE aligning the closest. nCRISPResso2 offers a viable alternative for CRISPR-Cas gRNA indel screening, especially with large amplicons unsuitable for Illumina sequencing. CRISPResso2's compatibility with Nanopore data enables cost-effective and efficient indel profiling, yielding results comparable to common Sanger sequencing-based methods. | |
| dc.format | Electronic | |
| dc.language | eng | |
| dc.publisher | SPRINGERNATURE | |
| dc.relation.ispartof | BMC Res Notes | |
| dc.relation.isbasedon | 10.1186/s13104-024-06861-1 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 0601 Biochemistry and Cell Biology, 1199 Other Medical and Health Sciences | |
| dc.subject.classification | Bioinformatics | |
| dc.subject.classification | 32 Biomedical and clinical sciences | |
| dc.subject.mesh | CRISPR-Cas Systems | |
| dc.subject.mesh | INDEL Mutation | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | RNA, Guide, CRISPR-Cas Systems | |
| dc.subject.mesh | Nanopore Sequencing | |
| dc.subject.mesh | Sheep | |
| dc.subject.mesh | Horses | |
| dc.subject.mesh | Gene Editing | |
| dc.subject.mesh | Myostatin | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Sheep | |
| dc.subject.mesh | Horses | |
| dc.subject.mesh | INDEL Mutation | |
| dc.subject.mesh | Myostatin | |
| dc.subject.mesh | CRISPR-Cas Systems | |
| dc.subject.mesh | Gene Editing | |
| dc.subject.mesh | Nanopore Sequencing | |
| dc.subject.mesh | RNA, Guide, CRISPR-Cas Systems | |
| dc.subject.mesh | CRISPR-Cas Systems | |
| dc.subject.mesh | INDEL Mutation | |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | RNA, Guide, CRISPR-Cas Systems | |
| dc.subject.mesh | Nanopore Sequencing | |
| dc.subject.mesh | Sheep | |
| dc.subject.mesh | Horses | |
| dc.subject.mesh | Gene Editing | |
| dc.subject.mesh | Myostatin | |
| dc.title | CRISPR-Cas guide RNA indel analysis using CRISPResso2 with Nanopore sequencing data. | |
| dc.type | Journal Article | |
| utslib.citation.volume | 17 | |
| utslib.location.activity | England | |
| utslib.for | 0601 Biochemistry and Cell Biology | |
| utslib.for | 1199 Other Medical and Health Sciences | |
| pubs.organisational-group | University of Technology Sydney | |
| pubs.organisational-group | University of Technology Sydney/Faculty of Science | |
| pubs.organisational-group | University of Technology Sydney/All Manual Groups | |
| pubs.organisational-group | University of Technology Sydney/All Manual Groups/Australian Institute for Microbiology & Infection (AIMI) | |
| pubs.organisational-group | University of Technology Sydney/All Manual Groups/Australian Institute for Microbiology & Infection (AIMI)/Associate Member | |
| utslib.copyright.status | open_access | * |
| dc.rights.license | This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ | |
| dc.date.updated | 2024-08-21T03:48:57Z | |
| pubs.issue | 1 | |
| pubs.publication-status | Published online | |
| pubs.volume | 17 | |
| utslib.citation.issue | 1 |
Abstract:
OBJECTIVE: Insertion and deletion (indel) analysis of CRISPR-Cas guide RNAs (gRNAs) is crucial in gene editing to assess gRNA efficiency and indel frequency. This study evaluates the utility of CRISPResso2 with Oxford Nanopore sequencing data (nCRISPResso2) for gRNA indel screening, compared to two common Sanger sequencing-based methods, TIDE and ICE. To achieve this, sheep and horse fibroblasts were transfected with Cas9 and a gRNA targeting the myostatin (MSTN) gene. DNA was subsequently extracted, and PCR products exceeding 600 bp were sequenced using both Sanger and Nanopore sequencing. Indel profiling was then conducted using TIDE, ICE, and nCRISPResso2. RESULTS: Comparison revealed close correspondence in indel formation among methods. For the sheep MSTN gRNA, indel percentages were 52%, 58%, and 64% for TIDE, ICE, and nCRISPResso2, respectively. Horse MSTN gRNA showed 81%, 87%, and 86% edited amplicons for TIDE, ICE, and nCRISPResso2. The frequency of each type of indel was also comparable among the three methods, with nCRISPResso2 and ICE aligning the closest. nCRISPResso2 offers a viable alternative for CRISPR-Cas gRNA indel screening, especially with large amplicons unsuitable for Illumina sequencing. CRISPResso2's compatibility with Nanopore data enables cost-effective and efficient indel profiling, yielding results comparable to common Sanger sequencing-based methods.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph
